The best cancer hospitals in the US for 2025–2026 include MD Anderson Cancer Center, Memorial Sloan Kettering, Dana-Farber Brigham Cancer Center, Mayo Clinic Rochester, and Johns Hopkins Hospital. These institutions lead in advanced treatments like CAR-T cell therapy, proton therapy, immunotherapy, and AI-powered diagnostics—evaluated across patient outcomes, research output, and clinical innovation.
A cancer diagnosis changes everything. Suddenly, the most important decision you’ll make isn’t about treatment itself—it’s about where to get treated. The right hospital can mean access to clinical trials years before a therapy reaches the mainstream, specialists who see hundreds of cases like yours each year, and technologies that simply aren’t available anywhere else.
With more than 850 US hospitals evaluated by U.S. News & World Report for its 2025–2026 Best Hospitals rankings, and fewer than 13% earning a Best Hospitals designation across specialties, the gap between a top cancer center and an average one is significant. This post breaks down the best cancer hospitals in the United States, what makes each one exceptional, and what advanced treatment options set them apart.
Whether you’re navigating a new diagnosis or researching options for a loved one, this guide gives you the facts you need to make an informed decision.
What Makes a Cancer Hospital “Advanced”?
Not all cancer hospitals are built the same. Elite cancer centers distinguish themselves across several dimensions:
- Research integration: On-site research labs that feed directly into patient care, giving patients early access to experimental therapies and clinical trials
- Multidisciplinary care teams: Oncologists, surgeons, radiologists, pathologists, and palliative care specialists collaborating on every case
- Technology investment: Proton therapy centers, robotic surgery systems, AI-assisted diagnostics, and precision genomic testing
- Volume and specialization: High patient volumes in specific cancer types translate to greater expertise and better outcomes
- Clinical trial access: Active enrollment in Phase I, II, and III trials for new drugs, immunotherapies, and combination treatments
Rankings from U.S. News & World Report (2025–2026) and Newsweek‘s World’s Best Specialized Hospitals 2026 both reflect these criteria, drawing on patient outcomes, peer recommendations from medical professionals, accreditation data, and patient experience metrics.
The Top Cancer Hospitals in the US for 2025–2026
1. University of Texas MD Anderson Cancer Center (Houston)
MD Anderson has ranked #1 in the US for cancer care for 11 consecutive years, according to U.S. News & World Report‘s 2025–2026 rankings published July 29, 2025. Newsweek‘s 2026 global oncology ranking places MD Anderson second in the world—behind only Memorial Sloan Kettering.
What sets MD Anderson apart is the sheer breadth of its research pipeline and the depth of its clinical specialization. The center operates one of the largest proton therapy programs in the world. A Phase III clinical trial conducted at MD Anderson demonstrated that proton therapy provides both a survival benefit and quality-of-life improvement over conventional radiation for certain cancers—level one evidence that is reshaping treatment guidelines globally.
MD Anderson also runs extensive immunotherapy and precision oncology programs, with specialists dedicated to rare and complex cancer types. For patients with difficult diagnoses, access to this level of expertise is often the difference between standard care and a tailored treatment plan built around their specific tumor biology.
2. Memorial Sloan Kettering Cancer Center (New York City)
Memorial Sloan Kettering Cancer Center (MSK) holds the #1 spot in Newsweek‘s 2026 global oncology ranking and ranks #2 in the US according to U.S. News. MSK’s research output in 2025 alone reflects why it consistently tops global lists.
Among MSK’s most significant advances in 2025:
- SCORPIO, an AI-based model developed with the Tisch Cancer Institute at Mount Sinai, uses routine blood tests to predict whether patients will respond to immune checkpoint inhibitors. Published January 6, 2025, in Nature Medicine, SCORPIO outperformed both FDA-approved biomarkers currently used for this purpose—and costs significantly less to run.
- Readymade CAR T cell therapy: MSK researchers demonstrated a new approach that could allow CAR T cells from healthy donors to be mass-produced and stored for immediate patient use. Published January 30, 2025, in Nature, this advance addresses one of CAR T therapy’s biggest limitations—the time and cost of creating custom treatments from each patient’s own cells.
- DeepHeme, an AI diagnostic tool co-developed with UCSF and UC Berkeley, uses nearly 50,000 annotated cell images to diagnose blood and bone marrow cancers with expert-level accuracy. The tool reduces diagnosis time from over 30 minutes to seconds, published June 11, 2025, in Science Translational Medicine.
MSK also partners with AWS to integrate AI across its cancer research programs—a collaboration aimed at accelerating discovery and improving treatment matching at scale.
3. Dana-Farber Brigham Cancer Center (Boston)
Dana-Farber Brigham Cancer Center holds the #3 spot in U.S. News‘s 2025–2026 rankings and ranks 15th globally in Newsweek‘s 2026 list. This is the 25th consecutive year Dana-Farber Brigham has earned national recognition for excellence—a track record that speaks for itself.
The center earned high-performing designations in several specific cancer types and procedures for 2025–2026, including:
- Colon cancer surgery
- Gynecological cancer surgery
- Leukemia, lymphoma, and myeloma
- Lung cancer surgery
- Prostate cancer surgery
Dana-Farber’s patient-first model integrates “compassionate, highly specialized clinical care combined with revolutionary science,” according to Dr. Benjamin L. Ebert, president and CEO of Dana-Farber Cancer Institute. The hospital’s deep affiliation with Harvard Medical School gives patients access to one of the most research-rich environments in oncology.
4. Mayo Clinic Rochester (Minnesota)
Mayo Clinic Rochester ranks #4 in the US per U.S. News and #5 globally in Newsweek‘s 2026 oncology rankings. Mayo’s strength lies in its multidisciplinary care model—specialists across departments collaborate on individual patient cases rather than operating in silos.
Mayo Clinic’s CAR-T Cell Therapy Program is one of the few in the country where staff are trained and certified to administer this highly specialized treatment. Mayo Clinic was among the original centers that participated in the clinical trials that led to FDA approval of CAR-T cell therapy. Today, the program treats patients with relapsed or refractory B-cell acute lymphoblastic leukemia, B-cell non-Hodgkin’s lymphoma, mantle cell lymphoma, follicular lymphoma, multiple myeloma, and other cancers through ongoing clinical studies.
Mayo also operates campus locations in Phoenix (ranked #21 nationally) and Jacksonville (ranked #24), giving patients across the country access to its integrated care model.
5. Johns Hopkins Hospital (Baltimore)
Johns Hopkins Hospital ranks #8 in the US per U.S. News and #10 globally in Newsweek‘s 2026 oncology ranking. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is a National Cancer Institute (NCI)-designated comprehensive cancer center, one of only 53 in the country to hold this designation.
Johns Hopkins is particularly known for its work in pancreatic cancer, head and neck cancers, and hematologic malignancies. The hospital’s proximity to Johns Hopkins University’s School of Medicine creates a direct pipeline between laboratory discovery and patient care—a model that has produced numerous first-in-human cancer trials.
Other Top-Ranked Cancer Centers Worth Knowing
The U.S. News 2025–2026 list highlights several other hospitals that deliver exceptional care:
- Massachusetts General Hospital, Boston (#5 nationally, #16 globally per Newsweek): Known for its pioneering work in proton therapy and precision oncology
- UCSF Medical Center, San Francisco (#7 nationally): Particularly strong in brain tumors and hematologic cancers
- City of Hope Comprehensive Cancer Center, Duarte, CA (#10 nationally, #48 globally): Specializes in blood cancers and bone marrow transplants, rated 4th in the nation for the fourth consecutive year in the 2025–2026 cycle
- Cleveland Clinic (#14 nationally, #20 globally per Newsweek): Offers a wide range of oncology services with strong outcomes data and PROMs implementation
What Advanced Cancer Treatment Options Are Available at These Centers?
The hospitals listed above are leaders not just because of their reputations, but because of the specific treatments they offer. Here’s a look at the key advanced therapies available at the country’s top cancer centers:
CAR-T Cell Therapy
Chimeric Antigen Receptor T-cell (CAR-T) therapy is one of the most significant innovations in oncology over the past decade. It involves extracting a patient’s immune T cells, genetically engineering them to recognize and destroy cancer cells, and reinfusing them. FDA-approved for several blood cancers, CAR-T is currently available at a limited number of certified centers, including Mayo Clinic, MSK, and Dana-Farber Brigham.
MSK’s 2025 research into “readymade” CAR-T cells—donor-sourced, mass-produced, and available off the shelf—could eventually expand access to far more patients.
Proton Therapy
Proton therapy delivers targeted radiation that minimizes damage to surrounding healthy tissue. MD Anderson operates one of the largest proton therapy programs in the country, and Phase III trial data from the center now confirms proton therapy produces measurable survival benefits over conventional radiation in select cancers. Massachusetts General Hospital also has a long-standing proton therapy program, one of the first in the country.
Immunotherapy and Immune Checkpoint Inhibitors
Immunotherapy has transformed outcomes for cancers once considered untreatable. MSK, MD Anderson, and Dana-Farber Brigham are all at the forefront of immune checkpoint inhibitor research and clinical application. MSK’s SCORPIO model now offers a cheaper, more accurate way to predict which patients will respond—reducing unnecessary treatment and improving outcomes.
AI-Powered Diagnostics and Precision Oncology
AI is rapidly changing cancer diagnosis. MSK’s DeepHeme tool brings expert-level blood cancer diagnosis down to seconds. MSK’s SCORPIO model predicts immunotherapy responses from routine blood work. These tools are moving from research papers to clinical practice—and top cancer hospitals are leading that transition.
Precision oncology—matching patients to treatments based on the genetic profile of their specific tumor—is now standard practice at the top centers. Nearly half of all new cancer drugs approved by the FDA over the past 25 years target specific genetic changes driving tumor growth, according to MSK research published January 9, 2025, in JAMA Oncology.
How to Choose the Right Cancer Hospital for Your Situation
The “best” cancer hospital depends heavily on the type of cancer, the stage at diagnosis, and individual patient needs. Here are the key factors to weigh:
- Cancer type and subtype: Some centers specialize in specific cancers. Dana-Farber Brigham leads in leukemia and lymphoma; Johns Hopkins in pancreatic cancer; MD Anderson across nearly every cancer type.
- Access to clinical trials: If standard treatments have been exhausted or you want access to experimental therapies, prioritize NCI-designated comprehensive cancer centers.
- Geography and logistics: CAR-T therapy and proton therapy require extended stays near the treatment center. Factor in proximity, housing options, and support services.
- Second opinions: All major cancer centers accept patients for second opinions. Getting a second opinion at an NCI-designated center before committing to a treatment plan is a widely recommended step.
Frequently Asked Questions About the Best Cancer Hospitals in the US
What is the #1 ranked cancer hospital in the US for 2025–2026?
The University of Texas MD Anderson Cancer Center in Houston holds the #1 ranking for cancer care in U.S. News & World Report‘s 2025–2026 Best Hospitals list, published July 29, 2025. MD Anderson has held this position for 11 consecutive years.
How does Newsweek rank the best cancer hospitals globally?
Newsweek‘s World’s Best Specialized Hospitals 2026 ranks Memorial Sloan Kettering Cancer Center #1 globally for oncology, followed by MD Anderson at #2. The ranking is based on a worldwide survey of healthcare professionals (85% weight), accreditation data (10%), and Patient Reported Outcome Measures (5%).
What is CAR-T cell therapy and which hospitals offer it?
CAR-T cell therapy is a form of immunotherapy that genetically engineers a patient’s T cells to target cancer. It is FDA-approved for several blood cancers. Certified CAR-T programs are available at Mayo Clinic, Memorial Sloan Kettering, Dana-Farber Brigham Cancer Center, and a limited number of other specialized centers.
Which cancer hospitals are best for clinical trial access?
NCI-designated comprehensive cancer centers, including MD Anderson, MSK, Dana-Farber Brigham, Johns Hopkins, and Mayo Clinic, offer the broadest access to Phase I, II, and III clinical trials. These institutions run trials across nearly every cancer type, including early-phase studies of experimental therapies not yet widely available.
Should I get a second opinion at a top cancer hospital before starting treatment?
Yes. Most oncologists recommend seeking a second opinion at an NCI-designated comprehensive cancer center before beginning treatment, particularly for complex, rare, or advanced-stage cancers. Many top centers offer second opinion services, and the information gathered can meaningfully change a treatment plan.
The Right Hospital Changes the Outcome
Cancer care has advanced dramatically. Treatments that were experimental a decade ago—CAR-T therapy, immune checkpoint inhibitors, proton therapy—are now standard practice at the country’s leading centers. The hospitals on this list don’t just treat cancer. They actively redefine what’s possible in oncology, from AI diagnostic tools that cut diagnosis time from 30 minutes to seconds, to readymade CAR-T cells that could eventually make immunotherapy accessible to patients who currently wait weeks for custom treatment.
For patients facing a cancer diagnosis, accessing one of these centers—whether for primary treatment, a second opinion, or enrollment in a clinical trial—is one of the most impactful steps available. Review the rankings, consider your specific diagnosis, and speak with your oncologist about whether a referral to a top-tier cancer center is the right next step.